BD (Becton, Dickinson and Company) announces the approval of the BD Saf-T-Intima™ Safety Integrated IV Catheter System for use in subcutaneous infusion therapies in Europe.
BD Saf-T-Intima™, approved by the British Standards Institution, has comfortable wings for stability and support, and an integral short extension tube to aid smooth insertion and reduce catheter movement during use. The pre-attached extension line reduces additional cost in assembly time, and reduces touch contamination risk. An increase to in-dwell times reduces overall costs of the therapy implemented, as well as in catheter materials, and staff time. BD Saf-T-Intima is DEHP free.
Subcutaneous infusion is increasingly and widely used for therapies such as rehydration, post-operative pain management, palliative care and paediatric care. It provides an affordable, effective, and less invasive alternative to the established intravenous route. Subcutaneous infusion also offers the benefit of many subcutaneous sites, rather than limited intravenous sites, which helps to increase patient comfort.
